Tessera Therapeutics

About:

Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.

Website: https://www.tesseratherapeutics.com

Twitter/X: tesseratx

Top Investors: Cormorant Asset Management, Abu Dhabi Investment Authority, Alaska Permanent Fund, T. Rowe Price, Saya Bio

Description:

Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.